Seller record · Telehealth service

Superpower

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The membership agreement refers only to licensed pharmacies that fill prescriptions ordered through the platform, and the answers to accredited partner pharmacies. 1 more criterion also fails; see the table below.

At a glance

SuperpowerTelehealth service

5/8criteria passed

Price: Compounded semaglutide $229 a month for members, after a membership priced at $349 a year
Sells: compounded semaglutide, sermorelin, NAD+ injection and nasal spray, and 8 more
FDA letters: None on file

Visit Superpower See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A lab-testing membership company that runs two blood panels a year and sells members compounded semaglutide and other compounded prescriptions, including sermorelin, NAD+, GHK-Cu cream, gonadorelin and a VIP nasal spray, after an eligibility questionnaire and review by its clinical team.

Operating entity Superpower Health, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Superpower's semaglutide page; Superpower's membership page
S2	Prescription gating	NOT VERIFIED	Superpower's semaglutide page; Superpower's membership page
S3	Pharmacy identification	FAIL	Superpower's membership page; Superpower's FAQ
S4	Compounding disclosure	PASS	Superpower's semaglutide page; Superpower's NAD+ injection page; Superpower's FAQ
S5	Analytical documentation	FAIL	Superpower's semaglutide page; Superpower's FAQ; Superpower's membership page
S6	Business address	PASS	Superpower's privacy page; Superpower's terms
S7	Price disclosure	PASS	Superpower's semaglutide page; Superpower's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe semaglutide page says a licensed physician on the clinical team reviews and approves each eligibility assessment, and the membership agreement says no prescription product is available until a provider from an independent medical group finds it appropriate.Source: Superpower's semaglutide page; Superpower's membership page.

S2NOT VERIFIEDWhether payment is taken before the medical questions did not resolve, because semaglutide is sold only to members and its start buttons lead to the membership purchase, while the product page lists an eligibility questionnaire and a clinical review before delivery and does not say when the $229 is charged. The check is open.Source: Superpower's semaglutide page; Superpower's membership page.

S3FAILNo filling pharmacy is named. The membership agreement refers only to licensed pharmacies that fill prescriptions ordered through the platform, and the answers to accredited partner pharmacies.Source: Superpower's membership page; Superpower's FAQ.

S4PASSThe semaglutide, NAD+, GHK-Cu, gonadorelin and VIP product pages state that compounded products have not been approved by the FDA, and the answers say compounded drug products are not FDA-approved.Source: Superpower's semaglutide page; Superpower's NAD+ injection page; Superpower's FAQ.

S5FAILNo certificate of analysis or lot document is published on the product pages, the answers or the membership agreement.Source: Superpower's semaglutide page; Superpower's FAQ; Superpower's membership page.

S6PASSSuperpower Health, Inc. at 11209 National Blvd, Unit #1016, Los Angeles, CA 90064, printed in the privacy policy. The terms name California law.Source: Superpower's privacy page; Superpower's terms.

S7PASSCompounded semaglutide at $229 a month with free shipping, sold only to members. The home page prices the membership at $349 a year, while the product pages print it as $17 a month billed annually. The other compounded products print no price.Source: Superpower's semaglutide page; Superpower's website.

S8PASSNo FDA warning letter names Superpower or Superpower Health, Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, sermorelin, NAD+ injection and nasal spray, GHK-Cu cream, gonadorelin, hCG, enclomiphene, VIP nasal spray, oxytocin, bremelanotide and tadalafil, metformin, low-dose naltrexone.

Other sellers of the same products

Who sells semaglutide Who sells sermorelin Who sells NAD+Who sells PT-141 Who sells GHK-Cu

Visit Superpower

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.